How Patents Contribute to High Drug Prices
Patents covering drugs selected for Medicare price negotiation show how patents influence drug prices.
Supplementing Dietary Supplement Regulation
Experts recommend measures to improve the regulation of dietary supplements.
HHS Selects Drugs for Medicare Price Negotiation
Biden Administration introduces price regulation to the pharmaceutical industry.
Patching Up Medical Device Cybersecurity Regulation
Researchers explore the optimal cost-benefit considerations of medical device cybersecurity risks.
Medical Debt Collection
Experts discuss how regulators can protect consumers from aggressive collection practices.
How Fixing the Past May Create Future Regulatory Problems
Scholar argues that generational amnesia may lead to ineffective regulatory solutions in the future.
Regulating Speech About a Drug’s Off-Label Uses
Scholar argues that FDA should adopt an evidenced-based approach to regulating drug manufacturers’ speech.
Protecting Medical Privacy on Your Wrist
Scholar argues for greater privacy protections of personal medical data collected by wearable health technologies.
States Renew Push for Medicaid Work Requirements
Scholars evaluate the impact of work requirements on Medicaid beneficiaries.
Patents Do Not Bar Public Pharma Policies
Merck misconstrues patent law in its recent Takings Clause challenge to Medicare’s price negotiation program.
The Right to Access Your Own Health Device Data
Scholars advocate mandated patient access to health device data.
The Troubling Reality of Wilderness Therapy
Scholars claim that unregulated wilderness therapy programs fail to protect the children participants.